Enhertu Shows Promise as First-Line Treatment for Metastatic Breast Cancer

Retrieved on: 2025-04-29 19:50:53

Tags for this article:

Click the tags to see associated articles and topics

Enhertu Shows Promise as First-Line Treatment for Metastatic Breast Cancer. View article details on hiswai:

Excerpt

Pertuzumab, sold under the brand name Perjeta, is a monoclonal antibody ... Enhertu belongs to a new class of drugs that uses lab-made antibodies ...

Article found on: www.verywellhealth.com